Contents Volume 15 · Issue 2 · 2021. Pages 155-332 13 articles
REVIEW
Adjuvant treatment strategy after curative resection for hepatocellular carcinoma
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 155-169 doi:10.1007/s11684-021-0848-3
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 170-177 doi:10.1007/s11684-020-0747-z
Metabolism and immunity in breast cancer
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 178-207 doi:10.1007/s11684-020-0793-6
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 208-220 doi:10.1007/s11684-020-0795-4
mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why?
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 221-231 doi:10.1007/s11684-020-0812-7
Recent advances in myeloid-derived suppressor cell biology
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 232-251 doi:10.1007/s11684-020-0797-2
RESEARCH ARTICLE
Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 252-263 doi:10.1007/s11684-021-0837-6
Clinical characteristics and risk factors for mortality in cancer patients with COVID-19
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 264-274 doi:10.1007/s11684-021-0845-6
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 275-291 doi:10.1007/s11684-020-0779-4
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 292-301 doi:10.1007/s11684-020-0806-5
DDB1- and CUL4-associated factor 8 plays a critical role in spermatogenesis
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 302-312 doi:10.1007/s11684-021-0851-8
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 313-329 doi:10.1007/s11684-020-0737-1
ERRATUM
Screening for main components associated with the idiosyncratic hepatotoxicity of a tonic herb,
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 330-332 doi:10.1007/s11684-020-0819-0